Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of $291.55 million. The enterprise value is $172.19 million.

Market Cap	291.55M
Enterprise Value	172.19M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

Cellectis has 72.59 million shares outstanding. The number of shares has increased by 10.73% in one year.

Current Share Class	n/a
Shares Outstanding	72.59M
Shares Change (YoY)	+10.73%
Shares Change (QoQ)	-1.36%
Owned by Insiders (%)	2.19%
Owned by Institutions (%)	16.76%
Float	46.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.66
Forward PS	4.71
PB Ratio	3.84
P/TBV Ratio	3.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.62, with a Debt / Equity ratio of 1.14.

Current Ratio	1.62
Quick Ratio	1.59
Debt / Equity	1.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.08

Financial Efficiency

Return on equity (ROE) is -65.33% and return on invested capital (ROIC) is -10.83%.

Return on Equity (ROE)	-65.33%
Return on Assets (ROA)	-5.84%
Return on Invested Capital (ROIC)	-10.83%
Return on Capital Employed (ROCE)	-18.48%
Weighted Average Cost of Capital (WACC)	16.46%
Revenue Per Employee	$347,568
Profits Per Employee	-$295,166
Employee Count	229
Asset Turnover	0.22
Inventory Turnover	n/a

Taxes

Income Tax	-423,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +161.44% in the last 52 weeks. The beta is 2.71, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	2.71
52-Week Price Change	+161.44%
50-Day Moving Average	3.71
200-Day Moving Average	3.64
Relative Strength Index (RSI)	55.60
Average Volume (20 Days)	40,628

Short Selling Information

The latest short interest is 383,347, so 0.70% of the outstanding shares have been sold short.

Short Interest	383,347
Short Previous Month	358,609
Short % of Shares Out	0.70%
Short % of Float	n/a
Short Ratio (days to cover)	8.40

Income Statement

In the last 12 months, Cellectis had revenue of $79.59 million and -$67.59 million in losses. Loss per share was -$0.67.

Revenue	79.59M
Gross Profit	79.59M
Operating Income	-33.08M
Pretax Income	-68.02M
Net Income	-67.59M
EBITDA	-21.75M
EBIT	-33.08M
Loss Per Share	-$0.67

Full Income Statement

Balance Sheet

The company has $206.38 million in cash and $86.69 million in debt, giving a net cash position of $119.69 million or $1.65 per share.

Cash & Cash Equivalents	206.38M
Total Debt	86.69M
Net Cash	119.69M
Net Cash Per Share	$1.65
Equity (Book Value)	75.90M
Book Value Per Share	1.05
Working Capital	90.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$39.40 million and capital expenditures -$2.36 million, giving a free cash flow of -$41.76 million.

Operating Cash Flow	-39.40M
Capital Expenditures	-2.36M
Depreciation & Amortization	11.33M
Net Borrowing	-16.19M
Free Cash Flow	-41.76M
FCF Per Share	-$0.58

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -41.56% and -84.92%.

Gross Margin	100.00%
Operating Margin	-41.56%
Pretax Margin	-85.45%
Profit Margin	-84.92%
EBITDA Margin	-27.33%
EBIT Margin	-41.56%
FCF Margin	n/a

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.73%
Shareholder Yield	-10.73%
Earnings Yield	-23.18%
FCF Yield	-14.32%

Analyst Forecast

The average price target for Cellectis is $8.33, which is 108.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.33
Price Target Difference	108.25%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	20.66%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -0.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.76
Piotroski F-Score	2